2-Hydroxypropyl beta-cyclodextrin (2-HP-β-CD) was converted into p(2-HP-β-CD) by direct chemical crosslinking method in microemulsion yielding smooth-surfaced particles with a few tens of micrometers in size. The p(2-HP-β-CD) microgels are biocompatible and blood compatible and possess the ability of controlled release of active agents.
Poly(2-hydroxypropyl-β-cyclodextrin) [p(HP-β-GCD)] particles with smooth surfaces and tens of micrometers in size were synthesized via a microemulsion technique using divinyl sulfone (DVS) as a crosslinker. Zeta potential analysis revealed a net negative surface charge across a wide pH range Evaluation of drug delivery capability using vancomycin, a relatively hydrophilic model drug, demonstrated a loading amount of 8.9% ± 0.2% and an encapsulation efficiency of 17.9% ± 0.4%. Also, 69.1 ± 2.4 μg/mg of vancomycin was released in 24 h, corresponds to 76.8% ± 1.9% of the loaded vancomycin amount within 24 hours. blood compatibility testing also demonstrated excellent compatibility, with a hemolysis index% (HI%) of 0.8% ± 0.06% and blood clotting index% (BCI%) of 87 ± 3, even at a concentration of 1000 μg/mL. Furthermore, cytotoxicity testing with L929 fibroblast cell further confirmed that the particles were non-toxic and mitigated drug toxicity at high concentrati
N. Sahiner, “ Hydroxypropyl Cyclodextrin Particles: Excellent Carriers for Controlled Release of Toxic and Labile Drugs With High Blood Compatibility and No Cytotoxicity,” Journal of Polymer Science (2026): 1–14, https://doi.org/10.1002/pola.70377.

